The company's software technology 510(k) clearance from the U.S. Food and Drug Administration on Dec. 24, setting the stage for the further commercialization of some of its products.
Visionquest is a New Mexico-based AI platform that provides solutions such as diabetic retinopathy screening and diagnosis for the healthcare industry.